quinolinic acid has been researched along with triazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domenici, MR; Falchi, M; Frank, C; Malchiodi-Albedi, F; Massotti, M; Pèzzola, A; Pintor, A; Popoli, P; Quarta, D; Reggio, R; Scarchilli, L; Tebano, MT | 1 |
| Domenici, MR; Popoli, P; Tebano, MT | 1 |
| Corsi, C; Gianfriddo, M; Melani, A; Pedata, F; Pèzzola, A; Popoli, P; Reggio, R | 1 |
| Domenici, MR; Frank, C; Nazzicone, V; Pèzzola, A; Pintor, A; Popoli, P; Potenza, RL; Reggio, R; Tebano, MT | 1 |
| Domenici, MR; Frank, C; Grieco, R; Martire, A; Pepponi, R; Pintor, A; Popoli, P; Potenza, RL; Tebano, MT | 1 |
| Calamandrei, G; Fusco, FR; March, ZD; Pezzola, A; Popoli, P; Scattoni, ML; Valanzano, A | 1 |
| Behan, WM; Stone, TW | 1 |
| Bantubungi, K; Blum, D; Greco, A; Minghetti, L; Pezzola, A; Popoli, P; Potenza, RL | 1 |
| Borsini, F; Galluzzo, M; Grieco, R; Pèzzola, A; Pintor, A; Popoli, P | 1 |
9 other study(ies) available for quinolinic acid and triazoles
| Article | Year |
|---|---|
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Topics: Animals; Behavior, Animal; Calcium; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Excitatory Amino Acid Antagonists; Gliosis; Glutamic Acid; Hippocampus; Huntington Disease; Long-Term Potentiation; Male; Maze Learning; Motor Activity; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazoles | 2002 |
SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
Topics: Animals; Binding Sites; Corpus Striatum; Drug Antagonism; Electric Stimulation; Electrophysiology; Hippocampus; In Vitro Techniques; Male; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Time Factors; Triazoles | 2002 |
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Extracellular Space; Glutamic Acid; Huntington Disease; Male; Microdialysis; Models, Animal; Neuroprotective Agents; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Time Factors; Triazoles | 2003 |
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cells, Cultured; Corpus Striatum; Drug Administration Routes; Electric Stimulation; Electroencephalography; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Microdialysis; Motor Activity; Neurons; Neuroprotective Agents; Neurotoxins; Pyrimidines; Quinolinic Acid; Rats; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synapses; Triazoles | 2003 |
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Topics: 4-Aminopyridine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Calcium; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Models, Biological; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Phenethylamines; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes; Synaptic Transmission; Triazines; Triazoles | 2004 |
Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Behavioral Symptoms; Corpus Striatum; Disease Models, Animal; Drug Interactions; Exploratory Behavior; Huntington Disease; Male; Maze Learning; Neuroprotective Agents; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Time Factors; Triazoles | 2007 |
Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist.
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain Injuries; Brain Ischemia; Cytoprotection; Drug Synergism; Hippocampus; Interleukin-1beta; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Pyramidal Cells; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles; Tumor Necrosis Factor-alpha | 2007 |
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain-Derived Neurotrophic Factor; Corpus Striatum; Cyclooxygenase 2; Disease Models, Animal; Drug Interactions; Free Radicals; Gene Expression Regulation; Male; Neurodegenerative Diseases; Neuroglia; Prostaglandins; Pyrimidines; Quinolinic Acid; Rats; Rats, Wistar; Triazoles | 2007 |
Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dose-Response Relationship, Drug; Glutamic Acid; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Quinolinic Acid; Rats; Rats, Wistar; Triazoles | 2008 |